HC Reform Update from Mark Sanna: It’s official. The drug industry’s chief lobbyists - the Pharmaceutical Research and Manufacturers of America - raised and spent at least $101.2 million in 2009 on advocacy efforts during the contentious health care debate, according to IRS documents the group filed in mid-November.